How Therapy Changes Effect Patients With 17P Deletion
Jacqueline Barrientos, M.D., Associate Professor, Division of Hematology and Medical Oncology,<br />Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Discusses How ...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
How Therapy Changes Affect Patients with 17P Deletion
Jacqueline Barrientos, M.D., Associate Professor, Division of Hematology and Medical Oncology,<br />Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Discusses How ...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Better To Combine Ibrutinib With Rituximab?
Jacqueline Barrientos, M.D., Associate Professor, Division of Hematology and Medical Oncology,<br />Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Discusses Bett...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Best Drug Sequence To Treat CLL
Jacqueline Barrientos, M.D., Associate Professor, Division of Hematology and Medical Oncology,<br />Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Discusses Best...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Tayloring Therapy: Therapy Intensification and Discontinuation
Hans Hammers MD, PhD Associate Professor of Internal Medicine in the Division of Hematology-Oncology at UT Southwestern Medical Center discusses Tayloring Therapy: Therapy Intensification and Disconti...
Author: kidneycancer
Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Normal and neoplastic stem cells: from discovery to treatments
Our understanding of stem cells has improved exponentially since their discovery, transforming our treatment of hematological malignancies and other diseases. Here, Irving Weissman, MD, of the Stanfor...
Author: VJHemOnc
Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts
A success story: IDH inhibitors for AML
Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting, held in Houston, TX, Alexander Perl, MD, of the University of Pennsylvania, Philadelphia, PA, describes how IDH inhibitors...
Author: VJHemOnc
Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts
MRD in lymphoma
From the 2018 Society of Hematologic Oncology (SOHO) in Houston, TX, Stephen Ansell, MD, PhD, of Mayo Clinic, Rochester, MN, discusses ways in which measuring measurable residual disease (MRD) may be ...
Author: VJHemOnc
Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Brentuximan vedotin for treating Hodgkin Lymphoma
From the 2018 Society of Hematologic Oncology (SOHO) in Houston, TX, Stephen Ansell, MD, PhD, of Mayo Clinic, Rochester, MN, discusses encouraging data on patients with Hodgkin lymphoma who received ...
Author: VJHemOnc
Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Promising treatments in CTCL
With new targets identified over the past few years, the development of precision medicine has expanded significantly. Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in H...
Author: VJHemOnc
Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts
MAVORIC trial: mogamulizumab for R/R CTCL
At the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Pierluigi Porcu from Sidney Kimmel Cancer Center, Philadelphia, PA, describes the MAVORIC trial (NCT01728805) investig...
Author: VJHemOnc
Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Gene-based treatments show positive outcomes in AML
Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Harry Erba of Duke University, Durham, NC, brings light upon the tendency of the healthcare community to fa...
Author: VJHemOnc
Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Gene-targeting therapies for AML
From the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Harry Erba of Duke University, Durham, NC, discusses the recently approved enasidenib and ivosidenib, which target I...
Author: VJHemOnc
Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Using inflammation to detect and monitor MDS
Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Valeria Santini, MD, of the University of Florence, Florence, Italy, discusses a new concept in the pathoph...
Author: VJHemOnc
Added: 09/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Research into the management of MLL
Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Rob Pieters, MD, PhD, of Princess Mxima Center for Pediatric Oncology, Utrecht, The Netherlands, discusses...
Author: VJHemOnc
Added: 09/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 21, 2018 Category: Cancer & Oncology Source Type: podcasts
